# Robert Manning

> Robert Manning is a Series A investor at Cherrystone Angel Group backing Biotechnology. See 14 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cherrystone Angel Group](https://shizune.co/investors/profile/cherrystone-angel-group)
- Location: Providence, United States
- Total investments: 14
- Last investment: Mar 2015
- Lead investor: 79%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/robert-manning-03584033

Robert Manning is a Series A investor at Cherrystone Angel Group in Providence focused on Biotechnology and Health Care. Robert Manning - President @ Gray's Point Investments LLC

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 21% |
| Health Care | 2 | 14% |
| Therapeutics | 2 | 14% |
| Medical Device | 2 | 14% |
| Diabetes | 1 | 7% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 14% |
| Convertible Note | 2 | 14% |
| Series B | 1 | 7% |
| Series C | 1 | 7% |
| Series D | 1 | 7% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Respiratory Motion | Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. |  | Series C | Mar 01, 2015 |  |
| Avaxia Biologics | Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. |  | Convertible Note | Dec 01, 2014 |  |
| Avaxia Biologics | Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. |  | Convertible Note | Apr 01, 2014 |  |
| Respiratory Motion | Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. |  | Convertible Note | Jul 01, 2013 |  |
| Avaxia Biologics | Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $11.5M | Series B | Jun 07, 2013 |  |
| Respiratory Motion | Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. |  | Convertible Note | Mar 01, 2013 |  |
| Avaxia Biologics | Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $6.4M | Series B | Dec 19, 2012 |  |
| Respiratory Motion | Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. |  | Convertible Note | Aug 01, 2012 |  |
| Avaxia Biologics | Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. |  | Convertible Note | Jun 01, 2012 |  |
| Avaxia Biologics | Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $4.1M | Series A | Feb 14, 2012 |  |

10 of 14 investments shown.

## Co-investors
- [Beta Fund](https://shizune.co/investors/profile/beta-fund) — VC Fund, 5 deals together
- [Boston Harbor Angels](https://shizune.co/investors/profile/boston-harbor-angels) — VC Fund, 5 deals together
- [Beacon Angels](https://shizune.co/investors/profile/beacon-angels) — VC Fund, 4 deals together
- [LaunchPad Venture](https://shizune.co/investors/profile/launchpad-venture-group) — VC Fund, 3 deals together
- [Mass Medical Angels](https://shizune.co/investors/profile/mass-medical-angels) — VC Fund, 3 deals together
- [Golden Seeds](https://shizune.co/investors/profile/golden-seeds) — VC Fund, 2 deals together

## About Cherrystone Angel Group

VC Fund · Providence, United States

Cherrystone Angel Group, founded in 2004 and comprised of over 60 Rhode Island members, is Rhode Island’s first organized angel investment group. Its members invest in early stage, typically pre-revenue companies, across the tri-state region. While it is the entrepreneur who drives the company — and on whom ultimate success depends —Cherrystone believes that good advice and focused expertise are vital to the success of any business venture. When Cherrystone invests, it not only brings money to the table but industry knowledge and connections that will make its business succeed. All its members are experienced and qualified investors who have either built their own companies or have extensive experience launching new business ventures. Their backgrounds include creating or working with manufacturing, distribution, technology, and service companies.

1 contacts available at Cherrystone Angel Group.

| Name | Title | Profile |
| --- | --- | --- |
| Robert Manning | Chairman | https://shizune.co/investors/profile/robert-manning |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Robert Manning invest in?

Robert Manning invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Series A and Convertible Note stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Robert Manning last invest?

The most recent investment recorded for Robert Manning closed in Mar 2015. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co